Raphael Pharmaceutical (RAPH) Other Working Capital Changes (2020 - 2025)
Raphael Pharmaceutical's (RAPH) quarterly Other Working Capital Changes came in at -$6000.0 in Q3 2025, down 300.0% year-on-year from $3000.0 in Q3 2024, and up 81.82% quarter-over-quarter from -$33000.0 in Q2 2025.
Raphael Pharmaceutical (RAPH) Other Working Capital Changes (2020 - 2025) Analysis & Trends
Raphael Pharmaceutical has disclosed Other Working Capital Changes across 6 years of filings, most recently posting -$6000.0 for Q3 2025.
- Other Working Capital Changes for Q3 2025 came in at -$6000.0, down 300.0% year-over-year; the trailing twelve-month figure through Sep 2025 was -$7000.0 (down 216.67% YoY), and the FY2024 annual result was -$1000.0, up 97.22% from the prior year.
- Other Working Capital Changes came in at -$6000.0 for Q3 2025 at Raphael Pharmaceutical, up from -$33000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $244000.0 in Q4 2021 to a low of -$170000.0 in Q1 2022.
- The 5-year median for Other Working Capital Changes is -$4000.0 (2021), against an average of -$11894.7.
- Peak annual rise in Other Working Capital Changes reached 483.33% in 2025, while the deepest fall reached 371.43% in 2025.
- Raphael Pharmaceutical's Other Working Capital Changes stood at $244000.0 in 2021, then slumped by 93.03% to $17000.0 in 2022, then plunged by 76.47% to $4000.0 in 2023, then sank by 175.0% to -$3000.0 in 2024, then sank by 100.0% to -$6000.0 in 2025.
- The last three Other Working Capital Changes figures came in at -$6000.0 (Q3 2025), -$33000.0 (Q2 2025), and $35000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Raphael Pharmaceutical | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -6,000.00 |
| Sep 30, 2025 | -6,000.00 |
| Jun 30, 2025 | -33,000.00 |
| Jun 30, 2025 | -33,000.00 |
| Mar 31, 2025 | 35,000.00 |
| Mar 31, 2025 | 35,000.00 |
| Dec 31, 2024 | -3,000.00 |
| Dec 31, 2024 | -3,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Jun 30, 2024 | -7,000.00 |
| Jun 30, 2024 | -7,000.00 |
| Mar 31, 2024 | 6,000.00 |
| Mar 31, 2024 | 6,000.00 |
| Dec 31, 2023 | 4,000.00 |
| Dec 31, 2023 | 4,000.00 |
| Sep 30, 2023 | -4,000.00 |
| Sep 30, 2023 | -4,000.00 |
| Jun 30, 2023 | -104,000.00 |
| Jun 30, 2023 | -104,000.00 |